Concepedia

Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality

Boikanyo Makubate, Peter T. Donnan, J A Dewar, A.M. Thompson, Colin McCowan

British Journal of Cancer · 2013 · 293 citations · 18 references

DOIFull text

Open access

Abstract

Low adherence to all adjuvant endocrine therapy for women with breast cancer, whether tamoxifen or AI, increases the risk of death.

References

18

Adherence to Medication

Lars Osterberg, Terrence F. Blaschke · New England Journal of Medicine · 2005 · 7.8K citations

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

The Lancet · 2011 · 3K citations · Full text

, , +11

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial

Jack Cuzick, Ivana Šestak, Michael Baum et al. · The Lancet Oncology · 2010 · 1.7K citations

, , +8

Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer

Dawn L. Hershman, Theresa Shao, Lawrence H. Kushi et al. · Breast Cancer Research and Treatment · 2010 · 868 citations

, , +11

Early Discontinuation and Nonadherence to Adjuvant Hormonal Therapy in a Cohort of 8,769 Early-Stage Breast Cancer Patients

Dawn L. Hershman, Lawrence H. Kushi, Theresa Shao et al. · Journal of Clinical Oncology · 2010 · 811 citations · Full text